Barkley Women's Reproductive Health
Practice Exam 200 Original Practice
Questions with Detailed Rationales
Table of Contents
1. Well-Woman Gynecology and Preventive Care (Questions 1–30)
2. Obstetrics and Antepartum Care (Questions 31–60)
3. Contraception and Family Planning (Questions 61–95)
4. Gynecologic Disorders and Infections (Questions 96–130)
5. Menopause and Hormonal Health (Questions 131–155)
6. Infertility and Reproductive Endocrinology (Questions 156–175)
7. Pharmacology and Primary Care (Questions 176–195)
8. Professional Issues and Ethics (Questions 196–200)
9. Answer Key Summary
10. Exam Preparation Tips
Section 1: Well-Woman Gynecology and Preventive Care (Questions
1–30)
1. A 22-year-old woman presents for her first Pap test. According to
current ASCCP guidelines, cervical cancer screening with cytology
alone should begin at age:
A. 18
B. 21
C. 25
D. 30
Correct Answer: B. 21
,Rationale: The American Society for Colposcopy and Cervical Pathology
(ASCCP) and USPSTF recommend initiating cervical cancer screening at
age 21, regardless of sexual history. Screening before age 21 is not
recommended because cervical cancer is rare in this age group and HPV
infections are typically transient.
2. A 30-year-old woman has a Pap test with HPV co-testing. The
result is negative for intraepithelial lesion or malignancy (NILM) and
HPV negative. The recommended follow-up is:
A. Repeat co-testing in 1 year
B. Repeat co-testing in 3 years
C. Repeat co-testing in 5 years
D. Colposcopy
Correct Answer: C. Repeat co-testing in 5 years
Rationale: For women aged 30–65 with a negative co-test (NILM and
HPV negative), routine screening is recommended no sooner than every
5 years. This interval is supported by multiple guidelines due to the low
risk of high-grade lesions in this population.
3. Which of the following is a known risk factor for cervical cancer?
A. Multiparity
B. Persistent infection with high-risk HPV types 16 and 18
C. Early menopause
D. Endometriosis
Correct Answer: B. Persistent infection with high-risk HPV types 16 and
18
Rationale: Persistent infection with oncogenic (high-risk) HPV types,
especially 16 and 18, is the primary cause of cervical cancer. Other risk
factors include smoking, immunosuppression, and multiple sexual
partners.
4. The quadrivalent HPV vaccine (Gardasil) protects against which
HPV types?
A. 6, 11, 16, 18
B. 16, 18, 31, 33
,C. 31, 33, 45, 52
D. 6, 11, 16, 18, 31, 33, 45, 52, 58
Correct Answer: A. 6, 11, 16, 18
Rationale: The quadrivalent vaccine covers HPV 6 and 11 (low-risk,
cause 90% of genital warts) and HPV 16 and 18 (high-risk, cause 70% of
cervical cancers). The 9-valent vaccine covers additional types including
31, 33, 45, 52, and 58.
5. A 45-year-old woman reports irregular, heavy menses and hot
flashes. Her FSH level is elevated. Which phase of reproductive
aging is she most likely experiencing?
A. Premenopause
B. Perimenopause (menopause transition)
C. Postmenopause
D. Primary ovarian insufficiency
Correct Answer: B. Perimenopause (menopause transition)
Rationale: The menopause transition (perimenopause) is characterized
by menstrual cycle irregularity, vasomotor symptoms, and elevated FSH
levels, typically occurring in the mid-to-late 40s. Postmenopause is
defined as 12 months of amenorrhea without a pathologic cause.
6. The most common cause of secondary amenorrhea in a
reproductive-age woman after pregnancy has been ruled out is:
A. Asherman's syndrome
B. Polycystic ovary syndrome (PCOS)
C. Hypothalamic amenorrhea
D. Premature ovarian failure
Correct Answer: B. Polycystic ovary syndrome (PCOS)
Rationale: PCOS is the most common endocrine cause of secondary
amenorrhea. Hypothalamic amenorrhea (functional) is also common, but
PCOS is the leading overall cause. Pregnancy must always be ruled out
first in any reproductive-age woman with amenorrhea.
, 7. A 27-year-old woman with PCOS is seeking contraception. Which
method also addresses her underlying hyperandrogenism and
menstrual irregularity?
A. Copper IUD
B. Combined oral contraceptives (COCs)
C. Progestin-only pill
D. Condoms
Correct Answer: B. Combined oral contraceptives (COCs)
Rationale: COCs suppress ovarian androgen production and increase
SHBG, reducing free testosterone. They also regulate menstrual cycles,
making them an ideal choice for women with PCOS who need
contraception.
8. A 52-year-old woman complains of vulvovaginal dryness and
dyspareunia. What is the most appropriate first-line treatment?
A. Oral hormone therapy
B. Vaginal moisturizers and lubricants
C. Topical testosterone
D. Antibiotics
Correct Answer: B. Vaginal moisturizers and lubricants
Rationale: For genitourinary syndrome of menopause (GSM), first-line
treatment includes vaginal moisturizers and lubricants. If symptoms
persist, low-dose vaginal estrogen is the next step. Oral hormone
therapy is not first-line for isolated vaginal symptoms.
9. A 35-year-old woman presents with a 3-month history of
irregular menstrual cycles, facial hair growth, and acne. Her BMI is
32 kg/m². What is the most likely diagnosis?
A. Hypothyroidism
B. Polycystic ovary syndrome
C. Cushing's syndrome
D. Premature ovarian failure
Correct Answer: B. Polycystic ovary syndrome
Practice Exam 200 Original Practice
Questions with Detailed Rationales
Table of Contents
1. Well-Woman Gynecology and Preventive Care (Questions 1–30)
2. Obstetrics and Antepartum Care (Questions 31–60)
3. Contraception and Family Planning (Questions 61–95)
4. Gynecologic Disorders and Infections (Questions 96–130)
5. Menopause and Hormonal Health (Questions 131–155)
6. Infertility and Reproductive Endocrinology (Questions 156–175)
7. Pharmacology and Primary Care (Questions 176–195)
8. Professional Issues and Ethics (Questions 196–200)
9. Answer Key Summary
10. Exam Preparation Tips
Section 1: Well-Woman Gynecology and Preventive Care (Questions
1–30)
1. A 22-year-old woman presents for her first Pap test. According to
current ASCCP guidelines, cervical cancer screening with cytology
alone should begin at age:
A. 18
B. 21
C. 25
D. 30
Correct Answer: B. 21
,Rationale: The American Society for Colposcopy and Cervical Pathology
(ASCCP) and USPSTF recommend initiating cervical cancer screening at
age 21, regardless of sexual history. Screening before age 21 is not
recommended because cervical cancer is rare in this age group and HPV
infections are typically transient.
2. A 30-year-old woman has a Pap test with HPV co-testing. The
result is negative for intraepithelial lesion or malignancy (NILM) and
HPV negative. The recommended follow-up is:
A. Repeat co-testing in 1 year
B. Repeat co-testing in 3 years
C. Repeat co-testing in 5 years
D. Colposcopy
Correct Answer: C. Repeat co-testing in 5 years
Rationale: For women aged 30–65 with a negative co-test (NILM and
HPV negative), routine screening is recommended no sooner than every
5 years. This interval is supported by multiple guidelines due to the low
risk of high-grade lesions in this population.
3. Which of the following is a known risk factor for cervical cancer?
A. Multiparity
B. Persistent infection with high-risk HPV types 16 and 18
C. Early menopause
D. Endometriosis
Correct Answer: B. Persistent infection with high-risk HPV types 16 and
18
Rationale: Persistent infection with oncogenic (high-risk) HPV types,
especially 16 and 18, is the primary cause of cervical cancer. Other risk
factors include smoking, immunosuppression, and multiple sexual
partners.
4. The quadrivalent HPV vaccine (Gardasil) protects against which
HPV types?
A. 6, 11, 16, 18
B. 16, 18, 31, 33
,C. 31, 33, 45, 52
D. 6, 11, 16, 18, 31, 33, 45, 52, 58
Correct Answer: A. 6, 11, 16, 18
Rationale: The quadrivalent vaccine covers HPV 6 and 11 (low-risk,
cause 90% of genital warts) and HPV 16 and 18 (high-risk, cause 70% of
cervical cancers). The 9-valent vaccine covers additional types including
31, 33, 45, 52, and 58.
5. A 45-year-old woman reports irregular, heavy menses and hot
flashes. Her FSH level is elevated. Which phase of reproductive
aging is she most likely experiencing?
A. Premenopause
B. Perimenopause (menopause transition)
C. Postmenopause
D. Primary ovarian insufficiency
Correct Answer: B. Perimenopause (menopause transition)
Rationale: The menopause transition (perimenopause) is characterized
by menstrual cycle irregularity, vasomotor symptoms, and elevated FSH
levels, typically occurring in the mid-to-late 40s. Postmenopause is
defined as 12 months of amenorrhea without a pathologic cause.
6. The most common cause of secondary amenorrhea in a
reproductive-age woman after pregnancy has been ruled out is:
A. Asherman's syndrome
B. Polycystic ovary syndrome (PCOS)
C. Hypothalamic amenorrhea
D. Premature ovarian failure
Correct Answer: B. Polycystic ovary syndrome (PCOS)
Rationale: PCOS is the most common endocrine cause of secondary
amenorrhea. Hypothalamic amenorrhea (functional) is also common, but
PCOS is the leading overall cause. Pregnancy must always be ruled out
first in any reproductive-age woman with amenorrhea.
, 7. A 27-year-old woman with PCOS is seeking contraception. Which
method also addresses her underlying hyperandrogenism and
menstrual irregularity?
A. Copper IUD
B. Combined oral contraceptives (COCs)
C. Progestin-only pill
D. Condoms
Correct Answer: B. Combined oral contraceptives (COCs)
Rationale: COCs suppress ovarian androgen production and increase
SHBG, reducing free testosterone. They also regulate menstrual cycles,
making them an ideal choice for women with PCOS who need
contraception.
8. A 52-year-old woman complains of vulvovaginal dryness and
dyspareunia. What is the most appropriate first-line treatment?
A. Oral hormone therapy
B. Vaginal moisturizers and lubricants
C. Topical testosterone
D. Antibiotics
Correct Answer: B. Vaginal moisturizers and lubricants
Rationale: For genitourinary syndrome of menopause (GSM), first-line
treatment includes vaginal moisturizers and lubricants. If symptoms
persist, low-dose vaginal estrogen is the next step. Oral hormone
therapy is not first-line for isolated vaginal symptoms.
9. A 35-year-old woman presents with a 3-month history of
irregular menstrual cycles, facial hair growth, and acne. Her BMI is
32 kg/m². What is the most likely diagnosis?
A. Hypothyroidism
B. Polycystic ovary syndrome
C. Cushing's syndrome
D. Premature ovarian failure
Correct Answer: B. Polycystic ovary syndrome
